Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature-Reference-Cited by-同舟云学术

Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature

Published:2021-04 Issue:2 Volume:45 Page:100668
ISSN:0147-0272
Container-title:Current Problems in Cancer
language:en
Short-container-title:Current Problems in Cancer

Author:

Arıkan Rukiye,Telli Tuğba Akın^ORCID,Demircan Nazım Can,Başoğlu Tuğba,Ercelep Özlem,Atasoy Beste Melek,Özgüven Salih,Dane Faysal,Yumuk Perran Fulden^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. NationalCancerInstitute: SEER Cancer Stat Facts: ThyroidCancer. https://seer.cancer.gov/statfacts/html/thyro.html.

2. Anaplastic thyroid cancer;Ranganath;Curr Opin Endocrinol Diabetes Obes,2015

3. Anaplastic thyroid carcinoma: Pathogenesis and emerging therapies;Smallridge;Clin Oncol,2010

4. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment;Nagaiah;J Oncol,2011

5. Early surgery and survival of patients with anaplastic thyroid carcinoma: Analysis of a case series referred to a single institution between 1999 and 2012;Brignardello;Thyroid,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in Mortality for Anaplastic Thyroid Cancer: Have We Made Progress?;Journal of Surgical Research;2024-10

2. Complete response of metastatic BRAF V600-mutant anaplastic thyroid cancer following adjuvant dabrafenib and trametinib treatment: A case report;World Journal of Clinical Cases;2023-09-26

3. Thyroid Cancer: From Genes to Treatment – Recent Developments;Thyroid Cancer - The Road From Genes to Successful Treatment;2023-07-19

4. Efficacy and Safety of Fuzheng Yiqi Kang-Ai Decoction Combined with External Irradiation in the Treatment of Undifferentiated Thyroid Carcinoma and Its Influence on Antiangiogenesis;Journal of Oncology;2022-05-16

5. Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study;Annals of Oncology;2022-04